Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Apr;43(4):436–442. doi: 10.1038/bjc.1981.64

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.

N M Bleehen, C R Wiltshire, P N Plowman, J V Watson, J R Gleave, A E Holmes, W S Lewin, C S Treip, T D Hawkins
PMCID: PMC2010639  PMID: 7016157

Abstract

The results are reported of a small clinical trial carried out to assess the potential value of the hypoxic cell radiosensitizer misonidazole in the radiation treatment of Grade 3 and 4 supratentorial astrocytomas. A total of 55 patients were randomly allocated to one of 3 treatment groups. No significant differences were seen between the median survivals of patients in the 2 control radiation groups and that of the third group in which oral misonidazole at a dose of 3 g/m2 preceded each of 4 weekly radiation doses. Possible reasons why no improvement was seen are discussed in detail.

Full text

PDF
436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcangeli G., Nervi C., Mauro F. Misonidazole also radiosensitizes some normal tissue. Br J Radiol. 1980 Jan;53(625):44–45. doi: 10.1259/0007-1285-53-625-44. [DOI] [PubMed] [Google Scholar]
  2. Ash D. V., Smith M. R., Bugden R. D. Distribution of misonidazole in human tumours and normal tissues. Br J Cancer. 1979 May;39(5):503–509. doi: 10.1038/bjc.1979.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Battermann J. J. Fast neutron therapy for advanced brain tumors. Int J Radiat Oncol Biol Phys. 1980 Mar;6(3):333–335. doi: 10.1016/0360-3016(80)90142-x. [DOI] [PubMed] [Google Scholar]
  4. Bleehen N. M. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies. Cancer Clin Trials. 1980 Fall;3(3):267–273. [PubMed] [Google Scholar]
  5. Bloom H. J. Combined modality therapy for intracranial tumors. Cancer. 1975 Jan;35(1):111–120. doi: 10.1002/1097-0142(197501)35:1<111::aid-cncr2820350116>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  6. Catterall M., Bloom H. J., Ash D. V., Walsh L., Richardson A., Uttley D., Gowing N. F., Lewis P., Chaucer B. Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study. Int J Radiat Oncol Biol Phys. 1980 Mar;6(3):261–266. doi: 10.1016/0360-3016(80)90131-5. [DOI] [PubMed] [Google Scholar]
  7. Chang C. H. Hyperbaric oxygen and radiation therapy in the management of glioblastoma. Natl Cancer Inst Monogr. 1977 Dec;46:163–169. [PubMed] [Google Scholar]
  8. Denekamp J., McNally N. J., Fowler J. F., Joiner M. C. Misonidazole in fractionated radiotherapy: are many small fractions best? Br J Radiol. 1980 Oct;53(634):981–990. doi: 10.1259/0007-1285-53-634-981. [DOI] [PubMed] [Google Scholar]
  9. Disch S., Saunders M. I., Anderson P., Urtasun R. C., Karcher K. H., Kogelnik H. D., Bleehen N., Phillips T. L., Wasserman T. H. The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol. 1978 Dec;51(612):1023–1024. doi: 10.1259/0007-1285-51-612-1023. [DOI] [PubMed] [Google Scholar]
  10. Fowler J. F., Adams G. E., Denekamp J. Radiosensitizers of hypoxic cells in solid tumors. Cancer Treat Rev. 1976 Dec;3(4):227–256. doi: 10.1016/s0305-7372(76)80012-6. [DOI] [PubMed] [Google Scholar]
  11. Garrett M. J., Hughes H. J., Freedman L. S. A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol. 1978 Mar;4(1):71–76. [PubMed] [Google Scholar]
  12. Gray A. J., Dische S., Adams G. E., Flockhart I. R., Foster J. L. Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol. 1976 Apr;27(2):151–157. doi: 10.1016/s0009-9260(76)80137-7. [DOI] [PubMed] [Google Scholar]
  13. HITCHCOCK E., SATO R. TREATMENT OF MALIGNANT GLIOMATA. J Neurosurg. 1964 Jun;21:497–505. doi: 10.3171/jns.1964.21.6.0497. [DOI] [PubMed] [Google Scholar]
  14. Hornsey S., White A. Isoeffect curve for radiation myelopathy. Br J Radiol. 1980 Feb;53(626):168–169. doi: 10.1259/0007-1285-53-626-168. [DOI] [PubMed] [Google Scholar]
  15. Jelsma R., Bucy P. C. The treatment of glioblastoma multiforme of the brain. J Neurosurg. 1967 Nov;27(5):388–400. doi: 10.3171/jns.1967.27.5.0388. [DOI] [PubMed] [Google Scholar]
  16. Laramore G. E., Griffin T. W., Gerdes A. J., Parker R. G. Fast neutron and mixed (neutron/photon) beam teletherapy for grades III and IV astrocytomas. Cancer. 1978 Jul;42(1):96–103. doi: 10.1002/1097-0142(197807)42:1<96::aid-cncr2820420116>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  17. Orton C. G., Ellis F. A simplification in the use of the NSD concept in practical radiotherapy. Br J Radiol. 1973 Jul;46(547):529–537. doi: 10.1259/0007-1285-46-547-529. [DOI] [PubMed] [Google Scholar]
  18. Salazar O. M., Rubin P., Feldstein M. L., Pizzutiello R. High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1733–1740. doi: 10.1016/0360-3016(79)90554-6. [DOI] [PubMed] [Google Scholar]
  19. Schotland D. L., DiMauro S., Bonilla E., Scarpa A., Lee C. P. Neuromuscular disorder associated with a defect in mitochondrial energy supply. Arch Neurol. 1976 Jul;33(7):475–479. doi: 10.1001/archneur.1976.00500070017003. [DOI] [PubMed] [Google Scholar]
  20. TAVERAS J. M., THOMPSON H. G., Jr, POOL J. L. Should we treat glioblastoma multiforme? A study of survival in 425 cases. Am J Roentgenol Radium Ther Nucl Med. 1962 Mar;87:473–479. [PubMed] [Google Scholar]
  21. Urtasun R., Band P., Chapman J. D., Feldstein M. L., Mielke B., Fryer C. Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med. 1976 Jun 17;294(25):1364–1367. doi: 10.1056/NEJM197606172942503. [DOI] [PubMed] [Google Scholar]
  22. Walker M. D., Strike T. A., Sheline G. E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1725–1731. doi: 10.1016/0360-3016(79)90553-4. [DOI] [PubMed] [Google Scholar]
  23. Wasserman T. H., Phillips T. L., Van Raalte G., Urtasun R., Partington J., Koziol D., Schwade J. G., Gangji D., Strong J. M. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol. 1980 Feb;53(626):172–173. doi: 10.1259/0007-1285-53-626-172. [DOI] [PubMed] [Google Scholar]
  24. Wiltshire C. R., Workman P., Watson J. V., Bleehen N. M. Clinical studies with misonidazole. Br J Cancer Suppl. 1978 Jun;3:286–289. [PMC free article] [PubMed] [Google Scholar]
  25. Workman P., Little C. J., Marten T. R., Dale A. D., Ruane R. J., Flockhart I. R., Bleehen N. M. Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography. J Chromatogr. 1978 May 1;145(3):507–512. doi: 10.1016/s0378-4347(00)81386-9. [DOI] [PubMed] [Google Scholar]
  26. Yuhas J. M. Misonidazole enhancement of acute and late radiation injury to the rat spinal cord. Br J Cancer. 1979 Jul;40(1):161–163. doi: 10.1038/bjc.1979.153. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES